Related Experiment Video
Updated: Jun 23, 2025

A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice
Published on: March 17, 2015
Roles of Thermosensitive Transient Receptor Channels TRPV1 and TRPM8 in Paclitaxel-Induced Peripheral Neuropathic
Wen-Wen Li1, Yan Zhao1, Huai-Cun Liu1
1Department of Human Anatomy, Histology & Embryology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Paclitaxel chemotherapy causes nerve pain by increasing TRPV1 activity and decreasing TRPM8 function in sensory neurons. Activating TRPM8 may relieve this pain by inhibiting TRPV1.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Paclitaxel chemotherapy can induce peripheral neuropathic pain (PIPNP).
- The roles of transient receptor potential ion channel vanilloid 1 (TRPV1) and melastatin 8 (TRPM8) in PIPNP are debated.
- TRPV1 acts as a nociceptor and heat sensor, while TRPM8 functions as a cold sensor.
Purpose of the Study:
- To investigate the roles of TRPV1 and TRPM8 in paclitaxel-induced peripheral neuropathic pain (PIPNP).
- To explore the potential of targeting these channels for pain relief.
Main Methods:
- Western blotting and immunofluorescence staining to assess protein expression in dorsal root ganglion (DRG) neurons.
- Calcium imaging to evaluate ion channel functional activity.
- Behavioral assessments (von Frey and brush tests) in rats to measure pain responses.
- Administration of TRPV1 antagonist capsazepine and TRPM8 agonists (menthol, WS-12).
Main Results:
- TRPV1 expression and activity were upregulated in DRG neurons of rats with PIPNP.
- TRPV1 antagonist capsazepine significantly inhibited mechanical hyperalgesia in PIPNP.
- TRPM8 expression and activity were decreased in DRG neurons during PIPNP.
- TRPM8 activation by menthol or WS-12 attenuated mechanical pain.
- Menthol application reduced TRPV1 activity, particularly in paclitaxel-treated neurons.
Conclusions:
- Upregulation of TRPV1 and downregulation of TRPM8 contribute to the development of PIPNP.
- Targeting TRPV1 and TRPM8 offers a potential therapeutic strategy for managing chemotherapy-induced neuropathic pain.
- Activation of TRPM8 may inhibit TRPV1 function, providing a mechanism for pain relief.
More Related Videos
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
Related Concept Videos
Thermosensation
Mechanically-gated Ion Channels
Nociception
Pain
Analgesia and Pain Management